Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health Care Reform Spending Much Lower Than Originally Estimated, Sebelius Testifies

This article was originally published in The Gray Sheet

Executive Summary

HHS Secretary Kathleen Sebelius defends fiscal 2013 budget, telling a House subcommittee that implementing the Affordable Care Act has so far cost only a fraction of the $1 billion per year originally forecast by the Congressional Budget Office.

You may also be interested in...



NIH Translational Science Center Defended On Capitol Hill

NIH Director Francis Collins March 20 defends his newly formed National Center for Advancing Translational Science, which is aimed at turning new diagnostic and therapeutic discoveries into viable products, before a highly suspicious House Appropriations Labor-HHS Subcommittee.

First Device Tax Deposits Due Next January

Although medical device taxes will need to be paid quarterly, the first deposits are due soon after the tax takes effect next January, KPMG tax experts say.

Contraceptive Devices Must Be Fully Covered By Private Plans, HHS Says

Starting Aug. 1, 2012, FDA-approved birth control devices must be fully covered by all new private health insurance plans and by Medicare, HHS Secretary Kathleen Sebelius said Aug. 1.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031037

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel